| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/16/2009 | US20090181988 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof |
| 07/16/2009 | US20090181986 Substituted heterocyclic compounds |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181945 Two cyclic cinnamide compound |
| 07/16/2009 | US20090181942 Tricyclic compounds |
| 07/16/2009 | US20090181941 Pyrrolopyrimidines and Pyrrolopyridines |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/16/2009 | CA2714888A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | CA2711845A1 Pyrrolopyrimidines and pyrrolopyridines |
| 07/16/2009 | CA2711782A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | CA2711500A1 Novel hiv integrase inhibitors and methods of use |
| 07/16/2009 | CA2711444A1 Method of synthesizing tetrahydrobiopterin |
| 07/16/2009 | CA2692955A1 A new method for preparation of zopiclone and its polymorphs |
| 07/15/2009 | EP2078720A1 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained and uses thereof |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078022A1 Spiro benzazepines used as vasopressin antagonists |
| 07/15/2009 | EP2078021A2 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 07/15/2009 | EP2078020A1 Fused ring heterocycle kinase modulators |
| 07/15/2009 | EP2078016A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP2078004A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 07/15/2009 | EP2077837A2 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 07/15/2009 | EP2077836A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 07/15/2009 | EP2077835A2 An alzheimer's disease progression inhibitor containing heterocyclic compound |
| 07/15/2009 | EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 07/15/2009 | EP1805150A4 Heterocyclical chromophore architectures |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | CN101484455A Fused heterocylic compounds and their use as mgglur5 modulators |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560455 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | US7559984 organic pigments; Diketopyrrolopyrrole dyes; for inkjet inks, and coated layers; non-aqueous pigment dispersion exhibiting a high dispersion quality and stability; high image quality with a high optical density |
| 07/14/2009 | CA2411414C A novel expanded porphyrin and a method for synthesis thereof |
| 07/14/2009 | CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086139A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 07/09/2009 | WO2009086130A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | WO2009086129A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | WO2009085990A2 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| 07/09/2009 | WO2009085988A1 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | WO2009085983A1 5-anilinoimidazopyridines and methods of use |
| 07/09/2009 | WO2009085980A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 07/09/2009 | WO2009085972A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | WO2009085913A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
| 07/09/2009 | WO2009085230A1 Inhibitors of pi3 kinase |
| 07/09/2009 | WO2009085185A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
| 07/09/2009 | WO2009084497A1 Methyl-substituted piperidine derivative |
| 07/09/2009 | WO2009084283A1 Cyclic compound, its metal complex, and modified metal complex |
| 07/09/2009 | WO2009084195A1 Porphyrazine dye and ink composition containing the same |
| 07/09/2009 | WO2009084024A2 A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof |
| 07/09/2009 | WO2009083532A2 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof |
| 07/09/2009 | WO2009083530A2 Fluoride processing method |
| 07/09/2009 | WO2009082881A1 Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof |
| 07/09/2009 | WO2009082845A1 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | US20090176852 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 07/09/2009 | US20090176851 Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 |
| 07/09/2009 | US20090176809 Raf inhibitor compounds and methods |
| 07/09/2009 | US20090176788 Imidazo[1,2-B]Pyridazines, Processes, Uses, Intermediates and Compositions |
| 07/09/2009 | US20090176774 Compounds and methods of use |
| 07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
| 07/09/2009 | US20090176645 Catalysts and methods for catalytic oxidation |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175852 Imidazopyrazines as protein kinase inhibitors |
| 07/09/2009 | US20090175775 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II) |
| 07/09/2009 | US20090173916 Fluorescent diketopyrrolopyrroles |
| 07/09/2009 | CA2812705A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747008A1 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747000A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections |
| 07/09/2009 | CA2710808A1 Cyclic compound, its metal complex and modified metal complex |
| 07/09/2009 | CA2710799A1 Fluoride processing method |
| 07/09/2009 | CA2710458A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | CA2710454A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | CA2710194A1 Inhibitors of p13 kinase |
| 07/09/2009 | CA2709710A1 Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors |
| 07/09/2009 | CA2709202A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 07/09/2009 | CA2707790A1 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| 07/09/2009 | CA2706735A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives, preparation process and medicinal use thereof |
| 07/09/2009 | CA2704125A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 07/08/2009 | EP2077268A1 Process for preparing inhibitors of nucleoside metabolism |
| 07/08/2009 | EP2077267A1 Fused heterocyclic compound |
| 07/08/2009 | EP2076569A1 Phthalocyanine dyes suitable for use in offset inks |
| 07/08/2009 | EP2076517A1 Spiro benzazepines as vasopressin antagonists |
| 07/08/2009 | EP2076516A2 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
| 07/08/2009 | EP2076515A1 Thiophene pyrazolopyrimidine compounds |
| 07/08/2009 | EP2076500A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
| 07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |